» Articles » PMID: 26070591

Hypothyroidism is a Risk Factor for New-Onset Diabetes: A Cohort Study

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2015 Jun 14
PMID 26070591
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify risk factors for the development of statin-associated diabetes mellitus (DM).

Research Design And Methods: The study was conducted in two phases. Phase one involved high-throughput in silico processing of a large amount of biomedical data to identify risk factors for the development of statin-associated DM. In phase two, the most prominent risk factor identified was confirmed in an observational cohort study at Clalit, the largest health care organization in Israel. Time-dependent Poisson regression multivariable models were performed to assess rate ratios (RRs) with 95% CIs for DM occurrence.

Results: A total of 39,263 statin nonusers were matched by propensity score to 20,334 highly compliant statin initiators in 2004-2005 and followed until the end of 2010. Within 59,597 statin users and nonusers in a multivariable model, hypothyroidism and subclinical hypothyroidism carried an increased risk for DM (RR 1.53 [95% CI 1.31-1.79] and 1.75 [1.40-2.18], respectively). Hypothyroidism increased DM risk irrespective of statin treatment (RR 2.06 [1.42-2.99] and 1.66 [1.05-2.64] in statin users and nonusers, respectively). Subclinical hypothyroidism risk for DM was prominent only upon statin use (RR 1.94 [1.13-3.34] and 1.20 [0.52-2.75] in statin users and nonusers, respectively). Patients with hypothyroidism treated with thyroid hormone replacement therapy were not at increased risk for DM.

Conclusions: Hypothyroidism is a risk factor for DM. Subclinical hypothyroidism-associated risk for DM is prominent only upon statin use. Identifying and treating hypothyroidism and subclinical hypothyroidism might reduce DM risk. Future clinical studies are needed to confirm the findings.

Citing Articles

A Two-Way Mendelian Randomization Analysis on the Link between Thyroid Activity Function and Coronary Atherosclerosis.

Li L, Leng J, Luo Y, Liu R, Song Z, Ye M Rev Cardiovasc Med. 2025; 25(12):453.

PMID: 39742251 PMC: 11683704. DOI: 10.31083/j.rcm2512453.


Efficacy of levothyroxine monotherapy in achieving clinical euthyroidism and its impact on weight loss in women with hypothyroidism and obesity.

Gokkaya N, Aydin K Sci Rep. 2024; 14(1):27822.

PMID: 39537668 PMC: 11561251. DOI: 10.1038/s41598-024-78185-w.


The hazard of using the Poisson model to cope with immortal time bias in the case of time-varying hazard.

Rea F, Morabito G, Corrao G, Cantarutti A BMC Med Res Methodol. 2024; 24(1):272.

PMID: 39522028 PMC: 11549743. DOI: 10.1186/s12874-024-02396-y.


Effects of thyroid hormones modify the association between pre-pregnancy obesity and GDM: evidence from a mediation analysis.

Alifu X, Chen Z, Zhuang Y, Chi P, Cheng H, Qiu Y Front Endocrinol (Lausanne). 2024; 15:1428023.

PMID: 39345886 PMC: 11427249. DOI: 10.3389/fendo.2024.1428023.


Genetically predicted hypothyroidism, thyroid hormone treatment, and the risk of cardiovascular diseases: a mendelian randomization study.

Zhang S, Yu H, Zhao Y, Gong A, Guan C, Chen S BMC Cardiovasc Disord. 2024; 24(1):479.

PMID: 39256710 PMC: 11386095. DOI: 10.1186/s12872-024-04132-2.